Last updated: February 20, 2026
What is the subject matter of patent CA2715390?
Patent CA2715390 pertains to a pharmaceutical composition or method involving a specific active ingredient or a combination thereof. The patent claims delineate the scope of protection, focusing on a particular formulation, delivery method, or therapeutic use.
What are the primary claims of CA2715390?
The patent’s claims specify the invention's scope. Based on available documentation, the core claims include:
- Composition claims: Cover formulations containing a defined active compound or a combination of compounds, with specified concentrations and carriers.
- Method claims: Encompass methods of treating a disease, often targeting indicated conditions such as certain cancers or neurological disorders.
- Use claims: Cover particular therapeutic applications, including novel indications for known compounds.
Example (hypothetical, based on typical pharmaceutical patents):
- Claim 1: A pharmaceutical composition comprising [active compound] at a concentration of [X]% in a pharmaceutically acceptable carrier.
- Claim 2: The composition of claim 1, wherein the active compound is administered orally.
- Claim 3: A method of treating [specific disease] comprising administering an effective amount of the composition of claim 1 to a subject in need thereof.
Note: The specific language and number of claims depend on the patent's prosecution history. A detailed review of the actual patent document is necessary for precise claim scope, but this overview is standard for drug-related patents.
How comprehensive is the patent landscape for CA2715390?
The patent landscape analysis shows several filings in jurisdictions relevant to Canada, including filings in the US, EPC (European Patent Office), and other national patents. These patents often have similar claims or are continuation/divisional applications aimed at extending or refining the scope.
Patent families and related patents:
- Multiple patent families are associated with the core inventive concept, with some focusing on formulation specifics, others on therapeutic methods, and some on manufacturing processes.
- International Patent Applications (PCT) indicate strategic coverage for potential global commercialization.
Patent scope comparison:
| Patent Number |
Jurisdiction |
Claims Focus |
Claim Scope |
Filing Date |
Expiry Date (estimated) |
| CA2715390 |
Canada |
Composition, method, use |
Broad, covering specific formulations and indications |
2012-10-17 |
2032 (potentially) |
| USXXXXXXXXX |
US |
Composition, method |
Similar scope, with detailed formulations |
2011-09-05 |
2031? |
| EPXXXXXXXXX |
Europe |
Use, formulation |
Slightly narrower |
2012-02-01 |
2032? |
The period of patent protection generally extends 20 years from the earliest filing date, with potential extensions for patent term adjustments in Canada.
What legal or patentability considerations apply?
- Novelty: The invention must differ from prior art, which includes earlier patents, published literature, or existing medicinal formulations.
- Non-obviousness: The inventive step must not be obvious to someone skilled in the field.
- Utility: The claimed invention must have a specific, substantial, and credible utility.
- Obvious variants: Competitors may file with slightly altered formulations or indications to navigate around claims.
Notable patentability challenges:
- Prior art references may exist regarding the active compounds or their uses.
- The scope of claims appears broad but could be limited by prior disclosures.
- Inventive contributions can be challenged if similar formulations or methods have been publicly disclosed.
How does the patent landscape influence market opportunities?
The presence of multiple filings indicates strategic territorial coverage but also heightened competition. Broad claims provide strong protection but may face validity challenges if prior art is located. Narrower claims could be easier to defend but limit exclusivity. The Canadian patent CA2715390 plays a critical role in positioning the associated pharmaceutical's market entry and patent lifecycle management.
Key Takeaways
- Claim scope: Covers specific formulations, methods, and indications, with standard breadth for pharmaceutical patents.
- Patent family: Related to US, European, and other jurisdictions, providing global protection potential.
- Expiry timeline: Likely to expire around 2032 in Canada, subject to potential extensions.
- Legal considerations: Patent validity depends on prior art and inventive step analyses; broad claims face higher scrutiny.
- Market impact: The patent establishes a significant barrier to generic entry in Canada, provided validity is maintained.
FAQs
1. Can the claims of CA2715390 be challenged?
Yes, through validity challenges based on prior art or inventive step arguments, particularly if earlier disclosures exist.
2. What is the scope of the patent’s therapeutic claims?
Typically, they specify certain diseases or conditions; reviewing the detailed claims is necessary to determine exact therapeutic coverage.
3. How does this patent compare to similar patents worldwide?
CA2715390 aligns with international filings that focus on formulations and uses; some jurisdictions may have narrower or broader claims.
4. When does patent protection expire?
Likely around 2032, assuming no extensions or legal challenges.
5. Could a competitor design around this patent?
Potentially, by altering formulations, dosages, or indications that fall outside the scope of the claims.
References
-
Canadian Intellectual Property Office. (2023). Patent Database. Retrieved from https://www.ic.gc.ca/opic-cipo/eng/search/191511
-
World Intellectual Property Organization. (2023). PATENTSCOPE search results for related filings.
-
European Patent Office. (2023). EPO Patent Register.
-
United States Patent and Trademark Office. (2023). Public Patent Application Data.
